Article
USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
Blood - 26 Jul 2018
Melo-Cardenas Johanna, Xu Yuanming, Wei Juncheng, Tan Can, Kong Sinyi, Gao Beixue, Montauti Elena, Kirsammer Gina, Licht Jonathan D, Yu Jindan, Ji Peng, Crispino John D, Fang Deyu
Abstract excerpt
Ras mutations are commonly observed in juvenile myelomonocytic leukemia (JMML) and chronic myelomonocytic leukemia (CMML). JMML and CMML transform into acute myeloid leukemia (AML) in about 10% and 50% of patients, respectively. However, how additional events cooperate with Ras to promote this transformation are largely unknown. We show that absence of the ubiquitin-specific peptidase 22 (USP22), a component of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
